Cargando…
Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis
Although numerous studies have reported the association between sarcopenia and the prognosis of hepatocellular carcinoma (HCC) patients, there is lack of a newer and more comprehensive meta-analysis. Herein, a comprehensive literature search was performed on PubMed, Web of Science, the Cochrane Libr...
Autores principales: | Guo, Yusheng, Ren, Yanqiao, Zhu, Licheng, Yang, Lian, Zheng, Chuansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845331/ https://www.ncbi.nlm.nih.gov/pubmed/36650190 http://dx.doi.org/10.1038/s41598-022-27238-z |
Ejemplares similares
-
Prognostic impact of sarcopenia in patients with hepatocellular
carcinoma treated with PD-1 inhibitor
por: Guo, Yusheng, et al.
Publicado: (2022) -
Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinoma
por: Sun, Tao, et al.
Publicado: (2023) -
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
por: Guo, Yusheng, et al.
Publicado: (2022) -
An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
por: Guo, Yusheng, et al.
Publicado: (2022) -
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
por: Ren, Yanqiao, et al.
Publicado: (2022)